John A Kanis1,2, Nicholas Norton3, Nicholas C Harvey4,5, Trolle Jacobson3, Helena Johansson6,7, Mattias Lorentzon6,8, Eugene V McCloskey7,9, Carl Willers3,10, Fredrik Borgström3,11. 1. Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia. w.j.Pontefract@sheffield.ac.uk. 2. Centre for Metabolic Bone Diseases, University of Sheffield Medical School, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. w.j.Pontefract@sheffield.ac.uk. 3. Quantify Research, Stockholm, Sweden. 4. MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK. 5. NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK. 6. Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia. 7. Centre for Metabolic Bone Diseases, University of Sheffield Medical School, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. 8. Geriatric Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 9. MRC Versus Arthritis Centre for Integrated Research in Musculoskeletal Ageing, Mellanby Centre for Bone Research, University of Sheffield, Sheffield, UK. 10. Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. 11. Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Stockholm, Sweden.
Abstract
This scorecard summarises key indicators of the burden of osteoporosis and its management in the 27 member states of the European Union, as well as the UK and Switzerland. The resulting scorecard elements, assembled on a single sheet, provide a unique overview of osteoporosis in Europe. INTRODUCTION: The scorecard for osteoporosis in Europe (SCOPE) is a project of the International Osteoporosis Foundation (IOF) that seeks to raise awareness of osteoporosis care in Europe. The aim of this project was to develop a scorecard and background documents to draw attention to gaps and inequalities in the provision of primary and secondary prevention of fractures due to osteoporosis. METHODS: The SCOPE panel reviewed the information available on osteoporosis and the resulting fractures for each of the 27 countries of the European Union plus the UK and Switzerland (termed EU27+2). The information obtained covered four domains: background information (e.g. the burden of osteoporosis and fractures), policy framework, service provision and service uptake, e.g. the proportion of men and women at high risk that do not receive treatment (the treatment gap). RESULTS: There was a marked difference in fracture risk among the EU27+2 countries. Of concern was the marked heterogeneity in the policy framework, service provision and service uptake for osteoporotic fracture that bore little relation to the fracture burden. For example, despite the wide availability of treatments to prevent fractures, in the majority of the EU27+2, only a minority of patients at high risk receive treatment even after their first fracture. The elements of each domain in each country were scored and coded using a traffic light system (red, orange, green) and used to synthesise a scorecard. The resulting scorecard elements, assembled on a single sheet, provide a unique overview of osteoporosis in Europe. CONCLUSIONS: The scorecard enables healthcare professionals and policy makers to assess their country's general approach to the disease and provide indicators to inform the future provision of healthcare.
This scorecard summarises key indicators of the burden of osteoporosis and its management in the 27 member states of the European Union, as well as the UK and Switzerland. The resulting scorecard elements, assembled on a single sheet, provide a unique overview of osteoporosis in Europe. INTRODUCTION: The scorecard for osteoporosis in Europe (SCOPE) is a project of the International Osteoporosis Foundation (IOF) that seeks to raise awareness of osteoporosis care in Europe. The aim of this project was to develop a scorecard and background documents to draw attention to gaps and inequalities in the provision of primary and secondary prevention of fractures due to osteoporosis. METHODS: The SCOPE panel reviewed the information available on osteoporosis and the resulting fractures for each of the 27 countries of the European Union plus the UK and Switzerland (termed EU27+2). The information obtained covered four domains: background information (e.g. the burden of osteoporosis and fractures), policy framework, service provision and service uptake, e.g. the proportion of men and women at high risk that do not receive treatment (the treatment gap). RESULTS: There was a marked difference in fracture risk among the EU27+2 countries. Of concern was the marked heterogeneity in the policy framework, service provision and service uptake for osteoporotic fracture that bore little relation to the fracture burden. For example, despite the wide availability of treatments to prevent fractures, in the majority of the EU27+2, only a minority of patients at high risk receive treatment even after their first fracture. The elements of each domain in each country were scored and coded using a traffic light system (red, orange, green) and used to synthesise a scorecard. The resulting scorecard elements, assembled on a single sheet, provide a unique overview of osteoporosis in Europe. CONCLUSIONS: The scorecard enables healthcare professionals and policy makers to assess their country's general approach to the disease and provide indicators to inform the future provision of healthcare.
Entities:
Keywords:
Burden of disease; Cost; Epidemiology; European Union; Osteoporosis; Policy framework; SCOPE; Scorecard; Service provision; Service uptake; Treatment gap; Treatment uptake
Authors: H Johansson; G Naureen; R Iqbal; L Jafri; A H Khan; M Umer; E Liu; L Vandenput; M Lorentzon; E V McCloskey; J A Kanis; N C Harvey Journal: Osteoporos Int Date: 2021-08-20 Impact factor: 4.507
Authors: Sören Möller; Michael K Skjødt; Lin Yan; Bo Abrahamsen; Lisa M Lix; Eugene V McCloskey; Helena Johansson; Nicholas C Harvey; John A Kanis; Katrine Hass Rubin; William D Leslie Journal: Osteoporos Int Date: 2021-10-01 Impact factor: 4.507
Authors: P Chotiyarnwong; E V McCloskey; N C Harvey; M Lorentzon; D Prieto-Alhambra; B Abrahamsen; J D Adachi; F Borgström; O Bruyere; J J Carey; P Clark; C Cooper; E M Curtis; E Dennison; M Diaz-Curiel; H P Dimai; D Grigorie; M Hiligsmann; P Khashayar; E M Lewiecki; P Lips; R S Lorenc; S Ortolani; A Papaioannou; S Silverman; M Sosa; P Szulc; K A Ward; N Yoshimura; J A Kanis Journal: Arch Osteoporos Date: 2022-06-28 Impact factor: 2.879